Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Hidden Vitamin in Beer May Prevent Obesity

By BiotechDaily International staff writers
Posted on 18 Jun 2012
A new study suggests that nicotinamide riboside (NR), a molecule found in beer and milk, could indirectly influence the activity of cell metabolism, thus preventing weight gain and diabetes, and improving muscular performance.

Researchers at the Federal Polytechnic School of Lausanne (EPFL; Switzerland) and other institutions conducted a study in mice to evaluate if increasing the supply of NR--a natural nicotinamide adenine dinucleotide (NAD+) precursor--could efficiently increases NAD+ levels in mammalian cells and tissues, increase SIRT1 and SIRT3 activities, prevent the detrimental metabolic effects of high-fat feeding, and enhances mitochondrial function and endurance performance. The researchers succeeded in showing that NR was capable of all of these functions, culminating in enhanced oxidative metabolism and protection against high-fat diet-induced metabolic abnormalities.

Mice on a high-fat diet fed NR over a ten-week period gained significantly less weight (60%) than mice eating the same diet, but without NR supplementation. In addition, none of the NR-treated mice had indications that they were developing diabetes, unlike the untreated mice. The mice fed NR supplements also had better endurance performance and improved energy expenditure compared to those who had not received the vitamins; and no side effects were evident in mice given the NR supplement. The study was published on June 6, 2012, in Cell Metabolism.

“The results indicate that the natural vitamin NR could be used as a nutritional supplement to ameliorate metabolic and age-related disorders characterized by defective mitochondrial function,” concluded lead author Carles Canto, PHD, of the EPFL. “Cells use what they need when they need it, and the rest is set aside without being transformed into any kind of deleterious form.”

The researchers believe that the increase in the NR molecule leads to an improvement in mitochondrial function, which is also believed to play a role in the aging process, and hypothesize that by stimulating mitochondrial with the NR molecule, longevity, as well as other health aspects, will also be improved.

Related Links:

Federal Polytechnic School of Lausanne



Channels

Genomics/Proteomics

view channel
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).

Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Lab Technologies

view channel
Image: The Leica DM2500 LED Microscope for clinical laboratories and research applications (Photo courtesy of Leica Microsystems).

New LED Microscope Completes Line of Clinical and Research Tools

A popular microscope used for both clinical and research applications is now available with LED illumination. The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.